Stories about Glucose

Subscribe to topic

Subscribe to Glucose

18.12.2019 – 14:07
Grünenthal Group
Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin) 8% Patch for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
Morristown, N.J. (ots) - · PDUFA date set for July 19, 2020 · If approved, QUTENZA would be the first topical treatment with a TRPV1 agonist indicated for the treatment of neuropathic pain associated with diabetic peripheral neuropathy. Averitas Pharma, Inc., a subsidiary of GRT US Holding, Inc. and member of the ...
more
04.12.2019 – 09:01
ForaCare Suisse AG
ForaCare Suisse AG Launches "Lab in the Pocket" Technology
ST. GALLEN, Switzerland (ots) - Innovative FORA 6 GTel Capability Provides 6 Tests with Single Device, SIM Direct-to-Telehealth Connectivity ForaCare Suisse AG announced the launch of its FORA 6 GTel multi-functional monitoring device with its new "Lab in the Pocket" technology (available on the GTel model and FORA 6 Series products). The innovative 6-in-1 monitoring technology provides seamless 3G/4G data transmission of ...
more
14.10.2019 – 17:27
Helmholtz Zentrum München
Discovery of potential novel therapeutic target for non-alcoholic fatty liver disease
more
19.09.2019 – 12:01
Novo Nordisk A/S
Tresiba® Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes
Barcelona, Spain (ots/PRNewswire) - According to new data from the CONCLUDE head-to-head trial, Tresiba® (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA1c, compared with insulin glargine U300 in adults with type 2 diabetes ...
more
05.08.2019 – 13:12
Technische Universität München
Dry feed for superfood producers: study investigates nutritional behavior of insects
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10516 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35635/ High resolution pictures: https://mediatum.ub.tum.de/1516504 NEWS RELEASE International study investigates nutritional behavior of insects Dry feed ...
more
09.04.2019 – 10:04
Diabeloop; ViCentra
Diabeloop and ViCentra Announce European Distribution Partnership
Paris (ots/PRNewswire) - Diabeloop comprehensive and personalized system integrates Kaleido patch pump for autonomous type 1 diabetes management ViCentra, the company behind the Kaleido insulin pump, and Diabeloop are announcing that they are entering into a mutual distribution agreement for selected European countries. Following successful clinical studies using ViCentra's Kaleido micro insulin pump, Diabeloop's DBLG1 ...
more
29.03.2019 – 16:00
ForaCare Suisse AG
ForaCare Suisse AG Distributor, AlphaDiab, Ranked One of the Fastest Growing Companies in France
ST. GALLEN, Switzerland, (ots) - ForaCare Suisse AG (ForaCare, FORA) announced its distributor, AlphaDiab was recently named by Les Echos and Statista as one of the top fastest growing companies in France. With an average annual growth rate of 46 percent and an increase between 2014 and 2017 of 212 percent, ...
more
19.03.2019 – 23:47
Merck KGaA
Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by ...
more
30.01.2019 – 08:12
ForaCare Suisse AG
2
ForaCare Suisse AG forms service-oriented partnership with B. Braun
more
25.10.2018 – 13:34
Helmholtz Zentrum München
Two-pronged approach - Novel combined therapy tackles excess fatty tissue
A new combined therapy for obesity and diabetes has been shown to suppress the appetite and at the same time increase energy expenditure. Scientists from the Helmholtz Zentrum München and the Technical University of Munich (TUM), partner institutions of the German Center for Diabetes Research (DZD), have reported their findings in 'Nature Communications'. "Obesity is ...
more
28.09.2018 – 10:01
Novo Nordisk A/S
International Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Have Cardiovascular Disease Risk Factors and/or Have Experienced a Cardiovascular Event
Bagsværd, Denmark (ots/PRNewswire) - - Cardiovascular disease (CVD) is the leading cause of disability and death in people with type 2 diabetes[1] - Despite the high incidence, 1 in 4 people with type 2 diabetes have never discussed, or cannot recall discussing, CVD risk factors with a doctor[2] - First-ever global ...
more
11.09.2018 – 14:31
Merck KGaA
BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a ...
more

1